×
Back to Agenda
Session 2 : Orphan Drug development and Approval in Regulatory Perspective
Session Chair(s)
Jin-A Jeong
General Manager, Hanmi, United States
Speaker(s)
Insook Kim, PhD
, United States
Clinical Pharmacology in Drug Development for Rare and Rare Pediatric
Myeong-Ah Chung
, NIFDS, Korea, Republic of
Orphan Drug Designation And A Regulatory Perspective
Chongwoo Yu, PhD
, United States
Importance Of Bioanalysis In Drug Development
Have an account?